Cargando…
Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD(65)-induced immune response
AIMS/HYPOTHESIS: A European Phase III trial of GAD formulated with aluminium hydroxide (GAD-alum) failed to reach its primary endpoint (preservation of stimulated C-peptide secretion from baseline to 15 months in type 1 diabetes patients), but subgroup analysis showed a clinical effect when particip...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487599/ https://www.ncbi.nlm.nih.gov/pubmed/28357504 http://dx.doi.org/10.1007/s00125-017-4263-x |